Literature DB >> 3396019

Results of the management of craniopharyngioma in children. An endocrinological approach to the treatment.

J K Kang1, J U Song.   

Abstract

The treatment results of 21 (1972-1982) patients with craniopharyngioma are reported who were treated either by surgery alone or by surgery and radiation therapy. The authors reviewed 14 patients (67%) who were less than 18 years of age at the time of surgery. The eradication was thought to be total in 7 children and subtotal in 7. Radiation was given as part of the initial therapy to 5 children after total excision and to 3 after subtotal removal. There were 2 postoperative deaths. All of the children suffered postoperative hormonal deficiencies. The results of this study indicate that total and subtotal removal followed by RT is an acceptable treatment for craniopharyngioma. Endocrine-deficient children, if treated properly, do well in terms of survival.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396019     DOI: 10.1007/bf00270902

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  19 in total

1.  Management of craniopharyngioma in children.

Authors:  H J Hoffman; E B Hendrick; R P Humphreys; J R Buncic; D L Armstrong; R D Jenkin
Journal:  J Neurosurg       Date:  1977-08       Impact factor: 5.115

2.  Visual complications following irradiation for pituitary adenomas and craniopharyngiomas.

Authors:  J R Harris; M B Levene
Journal:  Radiology       Date:  1976-07       Impact factor: 11.105

3.  Craniopharyngiomas in children and adults.

Authors:  J T Hoff; R H Patterson
Journal:  J Neurosurg       Date:  1972-03       Impact factor: 5.115

4.  Surgical experiences with craniopharyngiomas.

Authors:  H J Svien
Journal:  J Neurosurg       Date:  1965-08       Impact factor: 5.115

5.  Craniopharyngioma: the controversy regarding radiotherapy.

Authors:  A L Amacher
Journal:  Childs Brain       Date:  1980

6.  Recurrent craniopharyngiomas: therapeutic alternatives.

Authors:  W H Sweet
Journal:  Clin Neurosurg       Date:  1980

7.  Craniopharyngiomas: the subfrontal approach, or none at all?

Authors:  J Shillito
Journal:  Clin Neurosurg       Date:  1980

8.  Results of treatment for craniopharyngioma.

Authors:  K Mori; H Handa; T Murata; J Takeuchi; S Miwa; K Osaka
Journal:  Childs Brain       Date:  1980

9.  Role of radiation therapy in the management of craniopharyngiomas in children.

Authors:  I L Richmond; W M Wara; C B Wilson
Journal:  Neurosurgery       Date:  1980-05       Impact factor: 4.654

10.  Craniopharyngiomas in children.

Authors:  P W Carmel; J L Antunes; C H Chang
Journal:  Neurosurgery       Date:  1982-09       Impact factor: 4.654

View more
  5 in total

1.  Moyamoya syndrome precipitated by cranial irradiation for craniopharyngioma in children.

Authors:  Hyun Seok Lee; Ho Jun Seol; Doo-Sik Kong; Hyung Jin Shin
Journal:  J Korean Neurosurg Soc       Date:  2011-12-31

2.  Proliferative assessment of craniopharyngioma and epidermoid by nucleolar organizer region staining.

Authors:  S Niikawa; A Hara; W Zhang; N Sakai; H Yamada; K Shimokawa
Journal:  Childs Nerv Syst       Date:  1992-12       Impact factor: 1.475

3.  Giant craniopharyngioma with blindness reversed by surgery.

Authors:  B al-Wahhabi; A R Choudhury; K R al-Moutaery; M Aabed; A Faqeeh
Journal:  Childs Nerv Syst       Date:  1993-08       Impact factor: 1.475

4.  Trans-eyebrow supraorbital keyhole approach in suprasellar and third ventricular craniopharyngioma surgery: the experience of 27 cases and a literature review.

Authors:  Meiqin Cai; Zhuopeng Ye; Cong Ling; Baoyu Zhang; Bo Hou
Journal:  J Neurooncol       Date:  2018-11-03       Impact factor: 4.130

5.  Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma.

Authors:  Michael E Sughrue; Isaac Yang; Ari J Kane; Shanna Fang; Aaron J Clark; Derrick Aranda; Igor J Barani; Andrew T Parsa
Journal:  J Neurooncol       Date:  2010-06-10       Impact factor: 4.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.